Earnings NewsHealthcareBiogen Idec (NASDAQ:BIIB): Q4 EPS of $1.40 misses by $0.06. Revenue of $1.42B (+7% Y/Y) beats by...Jan. 28, 2013 6:33 AM ETBiogen Inc. (BIIB) StockBIIBBy: Gaurav Batavia, SA News EditorBiogen Idec (NASDAQ:BIIB): Q4 EPS of $1.40 misses by $0.06. Revenue of $1.42B (+7% Y/Y) beats by $30M. (PR)Recommended For YouMore Trending NewsSee More »About BIIB StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBIIB--Biogen Inc.Trending AnalysisTrending News